The JAK inhibitor Ruxolitinib offers an effective treatment strategy for peripheral T-cell lymphomas A. Proske, S. Kissel, A. Zwick,N. von Bubnoff,J. Duyster,C. DierksONCOLOGY RESEARCH AND TREATMENT（2016）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
